Scoring system to predict antitumor effects of p53-armed telomerase-specific oncolytic adenovirus

被引:0
|
作者
Sugimoto, Ryoma [1 ]
Kuroda, Shinji [2 ]
Yoshida, Yusuke [1 ]
Sakamoto, Masaki [1 ]
Hamada, Yuki [1 ]
Yagi, Chiaki [1 ]
Hashimoto, Masashi [1 ]
Kakiuchi, Yoshihiko [1 ]
Kikuchi, Satoru [2 ]
Kagawa, Shunsuke [2 ]
Tazawa, Hiroshi [3 ,4 ]
Urata, Yasuo [5 ]
Fujiwara, Toshiyoshi [3 ]
机构
[1] Okayama Univ, Dept Gastroenterol Surg, Okayama, Japan
[2] Okayama Univ, Grad Sch Med Pharm Sci, Dept Gastroenterol Surg, Okayama, Japan
[3] Okayama Univ, Grad Sch, Dept Gastroenterol Surg, Okayama, Japan
[4] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan
[5] Oncolys BioPharma Inc, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-3347
引用
收藏
页码:2210 / 2210
页数:1
相关论文
共 50 条
  • [1] Efficient virotherapy for osteosarcoma by telomerase-specific oncolytic adenovirus
    Guidong Li
    Hiroyuki Kawashima
    Akira Ogose
    Takashi Ariizumi
    Yongjun Xu
    Tetsuo Hotta
    Yasuo Urata
    Toshiyoshi Fujiwara
    Naoto Endo
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 1037 - 1051
  • [2] Multidisciplinary Cancer Therapy with Telomerase-Specific Oncolytic Adenovirus
    Fujiwara, Toshiyoshi
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    CURRENT CANCER THERAPY REVIEWS, 2015, 11 (03) : 178 - 187
  • [3] Molecular radiosensitization of p53-armed telomerase-dependent oncolytic adenovirus against human soft-tissue sarcoma
    Komatsubara, Tadashi
    Tazawa, Hiroshi
    Mochizuki, Yusuke
    Sugiu, Kazuhisa
    Omori, Toshinori
    Yamakawa, Yasuaki
    Osaki, Syuhei
    Hasei, Joe
    Fujiwara, Tomohiro
    Kunisada, Toshiyuki
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2018, 109 : 454 - 454
  • [4] Efficient virotherapy for osteosarcoma by telomerase-specific oncolytic adenovirus
    Li, Guidong
    Kawashima, Hiroyuki
    Ogose, Akira
    Ariizumi, Takashi
    Xu, Yongjun
    Hotta, Tetsuo
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    Endo, Naoto
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (06) : 1037 - 1051
  • [5] ANTITUMOR EFFECT OF TELOMERASE-SPECIFIC ONCOLYTIC ADENOVIRUS ON HUMAN BONE AND SOFT TISSUE SARCOMA CELLS
    Tazawa, Hiroshi
    Sasaki, Tsuyoshi
    Hasei, Jo
    Hashimoto, Yuuri
    Urata, Yasuo
    Ozaki, Toshifumi
    Fujiwara, Toshiyoshi
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 261 - 262
  • [6] Development of systemically-deliverable telomerase-specific oncolytic adenovirus
    Aoyama, Katsuyuki
    Kuroda, Shinji
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Butyrate enhances the antitumor efficacy of telomerase-specific oncolytic adenoviruses
    Sakamoto, Masaki
    Kuroda, Shinji
    Kakiuchi, Yoshihiko
    Hashimoto, Masashi
    Yagi, Chiaki
    Sugimoto, Ryoma
    Hamada, Yuki
    Yoshida, Yusuke
    Kadowaki, Daisuke
    Hanzawa, Shunya
    Kikuchi, Satoru
    Kagawa, Shunsuke
    Tazawa, Hiroshi
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2024, 115 : 1659 - 1659
  • [8] Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells
    Watanabe, Y.
    Hashimoto, Y.
    Kagawa, S.
    Kawamura, H.
    Nagai, K.
    Tanaka, N.
    Urata, Y.
    Fujiwara, T.
    CANCER GENE THERAPY, 2012, 19 (11) : 767 - 772
  • [9] Telomerase-specific oncolytic adenovirus: Antitumor effects on radiation-resistant head and neck squamous cell carcinoma cells
    Takahashi, Hideaki
    Hyakusoku, Hiroshi
    Horii, Chihiro
    Takahashi, Masahiro
    Nishimura, Goshi
    Taguchi, Takahide
    Kondo, Norio
    Sakakibara, Atsuko
    Urata, Yasuo
    Sano, Daisuke
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (03): : 411 - 418
  • [10] Enhanced antitumor efficacy of telomerase-specific oncolytic adenovirus with valproic acid against human cancer cells
    Y Watanabe
    Y Hashimoto
    S Kagawa
    H Kawamura
    K Nagai
    N Tanaka
    Y Urata
    T Fujiwara
    Cancer Gene Therapy, 2012, 19 : 767 - 772